ada standards of care 2025 obesity pharmacotherapy glp-1 title%% %%page%% ADA 2025: Combination Treatment Reduces

Learn why lightheadedness happens, how to manage it with hydration, and tips for a safe weight loss journey.

Sarcopenia is an age-related syndrome characterized by a progressive and extensive decline in skeletal muscle mass and function, leading to serious impairment of the quality of life and poor health prognosis in older adults

Allodynia is a condition where normally non-painful stimuli—such as a light touch, temperature change, or even brushing your hair—cause pain

Researchers are exploring whether semaglutide drugs like Ozempic and Wegovy could help prevent cognitive decline

Is Semaglutide GLP-1 Effective for Medical Weight Loss?

This companion panel helps you get a clearer wellness snapshot-so you're tracking more than weight alone, with practical lab insights you can adjust your diet, improve your fitness routine, or simply stay informed about your body, this test provides a convenient way to monitor changes over time Liver Function and Cholesterol Check-In: Includes liver function and cholesterol markers to support a smarter metabolism check-in during your program-especially helpful when your habits, dose, or weight trend is shifting Added Awareness for Potential Pancreatic Stress: Amylase and Lipase trends provide important early awareness of pancreatic strain, a key concern for many GLP-1 users Kidney Function Awareness for Hydration Shifts: Appetite changes and lower intake can impact hydration